https://stockwhiz.ai/news/3-e-network-signs-core-9-mva-power-distribution-agreement-for-mikkeli--a9cc8500Stockwhizen2026-10-19T11:50:00.104Z3 E Network Signs Core 9 MVA Power Distribution Agreement for Mikkeli AI Compute Center in Finlandhttps://stockwhiz.ai/news/altius-provides-3rd-quarter-2026-project-generation-update-225083d3Stockwhizen2026-10-19T11:49:00.074ZAltius Provides 3rd Quarter 2026 Project Generation Updatehttps://stockwhiz.ai/news/accenture-federal-services-and-google-public-sector-establish-gemini-l-e7a74b9eStockwhizen2026-10-19T11:47:00.072ZAccenture Federal Services and Google Public Sector Establish Gemini Launchpads to Power Purpose-Built Agents Across Federal Missionshttps://stockwhiz.ai/news/golar-lng-limited-q3-2026-results-presentation-8ff2a943Stockwhizen2026-10-19T11:46:25.287ZGolar LNG Limited – Q3 2026 results presentationhttps://stockwhiz.ai/news/reg-golar-lng-limited-q3-2026-results-presentation-f859317fStockwhizen2026-10-19T11:46:25.048ZREG-Golar LNG Limited – Q3 2026 results presentationhttps://stockwhiz.ai/news/athene-announces-third-quarter-2026-fixed-income-investor-call-00fbd8d3Stockwhizen2026-10-19T11:45:00.117ZAthene Announces Third Quarter 2026 Fixed Income Investor Callhttps://stockwhiz.ai/news/chord-energy-provides-preliminary-3q26-operational-and-financial-resul-242961b3Stockwhizen2026-10-19T11:31:00.249ZChord Energy Provides Preliminary 3Q26 Operational and Financial Resultshttps://stockwhiz.ai/news/lindblad-expeditions-holdings-inc-to-report-2026-third-quarter-financi-a13d074dStockwhizen2026-10-19T11:30:02.228ZLINDBLAD EXPEDITIONS HOLDINGS, INC. TO REPORT 2026 THIRD QUARTER FINANCIAL RESULTS ON NOVEMBER 3, 2026https://stockwhiz.ai/news/chord-energy-announces-leadership-transition-9283db17Stockwhizen2026-10-19T11:30:01.026ZChord Energy Announces Leadership Transitionhttps://stockwhiz.ai/news/mako-mining-announces-q3-2026-production-results-with-gold-recovered-o-6d660e1bStockwhizen2026-10-19T11:30:01.005ZMako Mining Announces Q3 2026 Production Results with Gold Recovered of 12,743 oz Au (Sales of 11,581 oz Au), and Positive Permitting Updates at Mt. Hamilton and San Albinohttps://stockwhiz.ai/news/cytokinetics-announces-health-canada-approval-of-myqorzo-aficamten-for-901f20f8Stockwhizen2026-10-19T11:30:00.491ZCytokinetics Announces Health Canada Approval of MYQORZO® (aficamten) for the Treatment of Adults with Symptomatic Obstructive Hypertrophic Cardiomyopathyhttps://stockwhiz.ai/news/biogen-to-present-new-data-across-nephrology-portfolio-including-long--9c571fd3Stockwhizen2026-10-19T11:30:00.457ZBiogen to Present New Data Across Nephrology Portfolio, Including Long-term EMPAVELI® (pegcetacoplan) Phase 3 Results, at American Society of Nephrology (ASN) Kidney Weekhttps://stockwhiz.ai/news/phinia-to-participate-in-gabelli-s-50th-annual-automotive-symposium-a68eadd0Stockwhizen2026-10-19T11:30:00.372ZPHINIA to Participate in Gabelli’s 50th Annual Automotive Symposiumhttps://stockwhiz.ai/news/faeth-to-present-preclinical-data-on-piktor-in-hr-her2-breast-cancer-m-471b0d27Stockwhizen2026-10-19T11:30:00.366ZFaeth to Present Preclinical Data on PIKTOR in HR+/HER2- Breast Cancer Models at ESMO 2026https://stockwhiz.ai/news/aramark-to-host-conference-call-on-fourth-quarter-and-full-year-fiscal-163f4ad4Stockwhizen2026-10-19T11:30:00.363ZAramark to Host Conference Call on Fourth Quarter and Full Year Fiscal 2026 Resultshttps://stockwhiz.ai/news/rekor-systems-takes-legal-action-against-former-director-following-ext-b9ed1570Stockwhizen2026-10-19T11:30:00.352ZRekor Systems Takes Legal Action Against Former Director Following Extensive Investigation into Alleged Breaches of Fiduciary Duty in Connection with a December 2025 Financing with a Hedge Fundhttps://stockwhiz.ai/news/biogen-to-present-new-data-across-nephrology-portfolio-including-long--70328cf8Stockwhizen2026-10-19T11:30:00.337ZBiogen to Present New Data Across Nephrology Portfolio, Including Long-term EMPAVELI® (pegcetacoplan) Phase 3 Results, at American Society of Nephrology (ASN) Kidney Weekhttps://stockwhiz.ai/news/caliber-ceo-chris-loeffler-to-speak-on-public-companies-crypto-panel-a-68e81ff4Stockwhizen2026-10-19T11:30:00.274ZCaliber CEO Chris Loeffler to Speak on Public Companies & Crypto Panel at Tokenize! Las Vegas 2026https://stockwhiz.ai/news/cardinal-infrastructure-group-cdnl-enters-into-amended-agreement-for-a-f4098f52Stockwhizen2026-10-19T11:30:00.264ZCardinal Infrastructure Group (CDNL) Enters into Amended Agreement for Acquisition of Hughes Brothers Construction Inc.https://stockwhiz.ai/news/rekor-systems-takes-legal-action-against-former-director-following-ext-0f555789Stockwhizen2026-10-19T11:30:00.260ZRekor Systems Takes Legal Action Against Former Director Following Extensive Investigation into Alleged Breaches of Fiduciary Duty in Connection with a December 2025 Financing with a Hedge Fundhttps://stockwhiz.ai/news/papa-johns-summons-a-halloween-favourite-the-jack-o-lantern-pizza-retu-12d263f0Stockwhizen2026-10-19T11:30:00.254ZPapa Johns Summons a Halloween Favourite: The Jack-o’-Lantern Pizza Returnshttps://stockwhiz.ai/news/sl-green-refinances-245-park-avenue-for-2-0-billion-3e01950bStockwhizen2026-10-19T11:30:00.178ZSL Green Refinances 245 Park Avenue for $2.0 Billionhttps://stockwhiz.ai/news/glass-house-brands-reports-preliminary-unaudited-third-quarter-financi-809cb318Stockwhizen2026-10-19T11:30:00.151ZGlass House Brands Reports Preliminary Unaudited Third Quarter Financial Results and Resignation of John Nichols Jr. from Board of Directorshttps://stockwhiz.ai/news/cormedix-announces-fda-acceptance-for-priority-review-of-supplemental--bbeba20eStockwhizen2026-10-19T11:30:00.113ZCormedix Announces FDA Acceptance for Priority Review of Supplemental NDA for Rezzayo® (Rezafungin) for Prophylaxis of Invasive Fungal Diseaseshttps://stockwhiz.ai/news/organon-to-report-third-quarter-2026-results-in-its-regularly-schedule-8539ffa6Stockwhizen2026-10-19T11:30:00.076ZOrganon to Report Third Quarter 2026 Results in Its Regularly Scheduled Form 10-Q Filinghttps://stockwhiz.ai/news/ast-spacemobile-advances-space-based-cellular-broadband-in-europe-in-c-9fe5b227Stockwhizen2026-10-19T11:25:00.073ZAST SpaceMobile Advances Space-Based Cellular Broadband in Europe in Collaboration with European Mobile Network Operator Partnershttps://stockwhiz.ai/news/firstenergy-pennsylvania-electric-company-announces-extension-of-excha-308b4f52Stockwhizen2026-10-19T11:20:00.017ZFirstEnergy Pennsylvania Electric Company Announces Extension of Exchange Offer for its 4.150% Senior Notes Due 2028 and 4.550% Senior Notes Due 2031https://stockwhiz.ai/news/centrus-acquires-westerman-holdings-llc-bringing-a-key-supplier-in-hou-b892ae52Stockwhizen2026-10-19T11:19:11.256ZCentrus Acquires Westerman Holdings, LLC, Bringing a Key Supplier In-House and Diversifying Its Manufacturing Capacityhttps://stockwhiz.ai/news/reg-chemometec-a-s-invites-to-conference-call-on-november-6-2026-at-3--2a3b0915Stockwhizen2026-10-19T11:16:49.045ZREG-ChemoMetec A/S invites to conference call on November 6, 2026, at 3:00 PM CET to present Q1 2026/27 financial resultshttps://stockwhiz.ai/news/eyepoint-announces-strategic-prioritization-98bdcb9eStockwhizen2026-10-19T11:15:39.117ZEyePoint Announces Strategic Prioritizationhttps://stockwhiz.ai/news/out-of-hormuz-energy-shocks-the-ingredients-for-a-global-food-crisis-e17514beStockwhizen2026-10-19T11:15:00.021ZOut of Hormuz Energy Shocks, the Ingredients for a Global Food Crisishttps://stockwhiz.ai/news/domino-x27-s-invites-customers-to-give-the-greatest-gift-time-through--adb87164Stockwhizen2026-10-19T11:07:00.230ZDomino's® Invites Customers to Give the Greatest Gift: Time, Through St. Jude Thanks and Giving® Campaignhttps://stockwhiz.ai/news/ardagh-group-announces-sale-of-trivium-packaging-d68e128dStockwhizen2026-10-19T11:05:00.436ZArdagh Group Announces Sale of Trivium Packaginghttps://stockwhiz.ai/news/nrg-energy-inc-announces-quarterly-dividend-f6d0c272Stockwhizen2026-10-19T11:01:00.114ZNRG Energy, Inc. Announces Quarterly Dividendhttps://stockwhiz.ai/news/xencor-to-host-webcast-to-discuss-results-from-the-phase-1-study-of-xm-fae4db8dStockwhizen2026-10-19T11:01:00.073ZXencor to Host Webcast to Discuss Results From the Phase 1 Study of XmAb819 in Advanced Clear Cell Renal Cell Carcinomahttps://stockwhiz.ai/news/globe-life-inc-announces-third-quarter-2026-earnings-release-and-confe-85da8d52Stockwhizen2026-10-19T11:00:06.053ZGlobe Life Inc. Announces Third Quarter 2026 Earnings Release and Conference Callhttps://stockwhiz.ai/news/hornbeck-offshore-announces-third-quarter-2026-earnings-release-and-co-9419e3efStockwhizen2026-10-19T11:00:04.450ZHornbeck Offshore Announces Third Quarter 2026 Earnings Release and Conference Call Schedulehttps://stockwhiz.ai/news/insmed-launches-brinsupri-tablets-25-mg-brensocatib-hydrate-for-the-tr-c9db24a3Stockwhizen2026-10-19T11:00:03.452ZInsmed Launches BRINSUPRI® Tablets 25 mg (brensocatib hydrate) for the Treatment of Non-Cystic Fibrosis Bronchiectasis in Japanhttps://stockwhiz.ai/news/cme-group-expands-dairy-business-with-new-european-futures-and-options-c5c4cbe1Stockwhizen2026-10-19T11:00:03.251ZCME Group Expands Dairy Business with New European Futures and Optionshttps://stockwhiz.ai/news/ptc-to-announce-fourth-fiscal-quarter-and-full-year-2026-results-on-we-5cd96475Stockwhizen2026-10-19T11:00:02.253ZPTC to Announce Fourth Fiscal Quarter and Full Year 2026 Results on Wednesday, November 4, 2026https://stockwhiz.ai/news/ineo-announces-preliminary-q1-fiscal-2027-revenue-of-more-than-1-3-mil-6445a3c5Stockwhizen2026-10-19T11:00:01.879ZINEO Announces Preliminary Q1 Fiscal 2027 Revenue of More Than $1.3 Million and Adjusted EBITDA Near Break-Evenhttps://stockwhiz.ai/news/marker-therapeutics-awarded-2-6-million-fda-orphan-products-developmen-22927f84Stockwhizen2026-10-19T11:00:01.449ZMarker Therapeutics Awarded $2.6 Million FDA Orphan Products Development Grant to Advance MT-601 in Pancreatic Cancerhttps://stockwhiz.ai/news/gogo-unveils-galileo-roadmap-to-continue-enhancing-customer-investment-0393b253Stockwhizen2026-10-19T11:00:01.351ZGogo unveils Galileo roadmap to continue enhancing customer investments through the mid 2030s and beyondhttps://stockwhiz.ai/news/atyr-pharma-announces-research-collaboration-with-montefiore-einstein-938d8f8eStockwhizen2026-10-19T11:00:01.314ZaTyr Pharma Announces Research Collaboration with Montefiore Einsteinhttps://stockwhiz.ai/news/agility-robotics-announces-audit-committee-chair-for-planned-public-co-c787cb77Stockwhizen2026-10-19T11:00:01.290ZAgility Robotics Announces Audit Committee Chair for Planned Public-Company Boardhttps://stockwhiz.ai/news/iovance-highlights-til-cell-therapy-platform-across-solid-tumors-at-th-a134fe55Stockwhizen2026-10-19T11:00:01.260ZIovance Highlights TIL Cell Therapy Platform Across Solid Tumors at the European Society for Medical Oncology (ESMO) Congress 2026https://stockwhiz.ai/news/eyepoint-announces-topline-results-from-lucia-the-second-pivotal-phase-4f5fd2f5Stockwhizen2026-10-19T11:00:01.140ZEyePoint Announces Topline Results from LUCIA, the Second Pivotal Phase 3 Clinical Trial of DURAVYU™ in Wet AMDhttps://stockwhiz.ai/news/equipmentshare-raises-2026-financial-outlook-on-strong-performance-and-85301c46Stockwhizen2026-10-19T11:00:01.068ZEquipmentShare Raises 2026 Financial Outlook on Strong Performance and Customer Demandhttps://stockwhiz.ai/news/disc-medicine-announces-success-on-all-primary-and-secondary-endpoints-454ce7aeStockwhizen2026-10-19T11:00:01.005ZDisc Medicine Announces Success on All Primary and Secondary Endpoints in the Pivotal Phase 3 APOLLO Trial of Bitopertin in Adults and Adolescents with Erythropoietic Protoporphyria (EPP)https://stockwhiz.ai/news/shoals-technologies-group-inc-announces-third-quarter-2026-earnings-re-7868fa65Stockwhizen2026-10-19T11:00:00.923ZShoals Technologies Group, Inc. Announces Third Quarter 2026 Earnings Release Date and Conference Callhttps://stockwhiz.ai/news/lexeo-therapeutics-to-host-educational-event-focused-on-clinical-endpo-b68fd558Stockwhizen2026-10-19T11:00:00.897ZLexeo Therapeutics to Host Educational Event Focused on Clinical Endpoints and Outcome Measures in PKP2-ACMhttps://stockwhiz.ai/news/teamshares-retires-legacy-credit-facility-with-term-loan-maturing-4q-2-d695d646Stockwhizen2026-10-19T11:00:00.767ZTeamshares Retires Legacy Credit Facility with Term Loan Maturing 4Q 2030https://stockwhiz.ai/news/jazzcash-wins-silver-award-for-innovation-in-insurtech-at-money20-20-u-46b8c260Stockwhizen2026-10-19T11:00:00.710ZJazzCash Wins Silver Award for Innovation in InsurTech at Money20/20 USA 2026https://stockwhiz.ai/news/trigemx-bio-and-tcgx-acquisition-corp-announce-business-combination-ag-c44e2420Stockwhizen2026-10-19T11:00:00.624ZTriGemX Bio and TCGX Acquisition Corp. Announce Business Combination Agreement to Create Publicly Listed Company to Develop Elismetrep, a Potential First-in-Class Treatment for Migrainehttps://stockwhiz.ai/news/silgan-announces-strategic-portfolio-acceleration-establishes-partners-d87ed6d0Stockwhizen2026-10-19T11:00:00.580ZSilgan Announces Strategic Portfolio Acceleration; Establishes Partnership to Acquire Triviumhttps://stockwhiz.ai/news/trigemx-bio-and-tcgx-acquisition-corp-announce-business-combination-ag-182ff070Stockwhizen2026-10-19T11:00:00.537ZTriGemX Bio and TCGX Acquisition Corp. Announce Business Combination Agreement to Create Publicly Listed Company to Develop Elismetrep, A Potential First-in-Class Treatment for Migrainehttps://stockwhiz.ai/news/ses-ai-completes-ramp-of-korea-drone-battery-plant-to-one-million-ndaa-03fbff6dStockwhizen2026-10-19T11:00:00.495ZSES AI Completes Ramp of Korea Drone Battery Plant to One Million NDAA-Compliant Cells Per Year, and Plans to Further Expand to Three Million NDAA-Compliant Cells Per Year by Second Quarter 2027https://stockwhiz.ai/news/origin-agritech-announces-strategic-provincial-distribution-agreement--29e4a06dStockwhizen2026-10-19T11:00:00.495ZOrigin Agritech Announces Strategic Provincial Distribution Agreement for Corn Seeds in Shandong Province and Receives RMB 2.9 Million in Initial Paymentshttps://stockwhiz.ai/news/veradermics-oral-vdphl01-achieved-early-consistent-and-robust-hair-gro-d99ecdf7Stockwhizen2026-10-19T11:00:00.462ZVeradermics’ Oral VDPHL01 Achieved Early, Consistent, and Robust Hair Growth in Positive Phase 3 ‘304’ Clinical Trial in Male Pattern Hair Losshttps://stockwhiz.ai/news/parabilis-medicines-to-present-updated-clinical-data-for-zolucatetide--40e1bc7cStockwhizen2026-10-19T11:00:00.438ZParabilis Medicines to Present Updated Clinical Data for Zolucatetide in Patients with Desmoid Tumors at ESMO Congress 2026https://stockwhiz.ai/news/zipalertinib-demonstrates-clinically-meaningful-intracranial-antitumor-91ca0ce4Stockwhizen2026-10-19T11:00:00.416ZZipalertinib Demonstrates Clinically Meaningful Intracranial Antitumor Activity in Patients with NSCLC with EGFR Exon 20 Insertion or Uncommon EGFR Mutations and Active CNS Metastaseshttps://stockwhiz.ai/news/summit-therapeutics-announces-opening-of-global-phase-ii-study-of-ivon-cd4c908eStockwhizen2026-10-19T11:00:00.373ZSummit Therapeutics Announces Opening of Global Phase II Study of Ivonescimab-Based Regimens in Advanced Clear Cell Renal Cell Carcinomahttps://stockwhiz.ai/news/united-therapeutics-announces-fda-clearance-to-proceed-with-summit-cli-ec0cfb16Stockwhizen2026-10-19T11:00:00.330ZUnited Therapeutics Announces FDA Clearance to Proceed with SUMMIT Clinical Trial for Treprostinil SMI in PH-COPDhttps://stockwhiz.ai/news/origin-agritech-announces-strategic-provincial-distribution-agreement--fd2672afStockwhizen2026-10-19T11:00:00.292ZOrigin Agritech Announces Strategic Provincial Distribution Agreement for Corn Seeds in Shandong Province and Receives RMB 2.9 Million in Initial Paymentshttps://stockwhiz.ai/news/kamada-announces-participation-in-the-stifel-2026-healthcare-conferenc-f32a24c3Stockwhizen2026-10-19T11:00:00.259ZKamada Announces Participation in the Stifel 2026 Healthcare Conference and the Jefferies Global Healthcare Conference in London During November 2026https://stockwhiz.ai/news/tonix-pharmaceuticals-to-present-an-analysis-of-phase-3-data-on-tonmya-42b1d2baStockwhizen2026-10-19T11:00:00.226ZTonix Pharmaceuticals to Present an Analysis of Phase 3 Data on TONMYA® at the IASP 2026 World Congress on Painhttps://stockwhiz.ai/news/blacksky-to-host-third-quarter-2026-results-conference-call-a6b03740Stockwhizen2026-10-19T11:00:00.166ZBlackSky to Host Third Quarter 2026 Results Conference Callhttps://stockwhiz.ai/news/plug-power-appoints-dr-lee-sweetland-as-global-engineering-industriali-e5a377c5Stockwhizen2026-10-19T11:00:00.156ZPlug Power Appoints Dr. Lee Sweetland as Global Engineering Industrialization Leadhttps://stockwhiz.ai/news/monday-com-to-announce-third-quarter-2026-financial-results-on-monday--8a02e930Stockwhizen2026-10-19T11:00:00.083Zmonday.com to Announce Third Quarter 2026 Financial Results on Monday, November 9, 2026https://stockwhiz.ai/news/jazzcash-wins-silver-award-for-innovation-in-insurtech-at-money20-20-u-489a443fStockwhizen2026-10-19T11:00:00.047ZJazzCash Wins Silver Award for Innovation in InsurTech at Money20/20 USA 2026https://stockwhiz.ai/news/bristol-myers-squibb-to-showcase-next-generation-cancer-modalities-and-76faf29fStockwhizen2026-10-19T10:59:00.129ZBristol Myers Squibb to Showcase Next-Generation Cancer Modalities and Leadership Across Solid Tumors at ESMO 2026https://stockwhiz.ai/news/knox-and-palantir-partner-to-further-accelerate-delivery-of-software-t-0e17b831Stockwhizen2026-10-19T10:59:00.076ZKnox and Palantir Partner to Further Accelerate Delivery of Software through Largest Federal Cloudhttps://stockwhiz.ai/news/owlting-group-nasdaq-owls-issues-ceo-letter-to-shareholders-marking-on-a7fbaad1Stockwhizen2026-10-19T10:58:59.145ZOwlting Group (NASDAQ: OWLS) Issues CEO Letter to Shareholders Marking One Year on Nasdaqhttps://stockwhiz.ai/news/valor-energy-inc-enters-into-agreement-to-acquire-18mw-computing-cente-b0bbeef6Stockwhizen2026-10-19T10:58:00.211ZValor Energy Inc. Enters into Agreement to Acquire 18MW Computing Center in Youngstown, Ohiohttps://stockwhiz.ai/news/valor-energy-inc-enters-into-agreement-to-acquire-18mw-computing-cente-2219c592Stockwhizen2026-10-19T10:58:00.099ZValor Energy Inc. Enters into Agreement to Acquire 18MW Computing Center in Youngstown, Ohiohttps://stockwhiz.ai/news/ani-pharmaceuticals-announces-the-launch-of-duloxetine-delayed-release-c280acdeStockwhizen2026-10-19T10:55:00.092ZANI Pharmaceuticals Announces the Launch of Duloxetine Delayed-Release Capsuleshttps://stockwhiz.ai/news/the-geo-group-completes-redemption-of-all-senior-secured-notes-due-202-c41fdfe9Stockwhizen2026-10-19T10:55:00.084ZThe GEO Group Completes Redemption of All Senior Secured Notes Due 2029https://stockwhiz.ai/news/pentair-names-josh-cowley-executive-vice-president-and-chief-executive-b36824caStockwhizen2026-10-19T10:50:00.122ZPentair Names Josh Cowley Executive Vice President and Chief Executive Officer, Pentair Poolhttps://stockwhiz.ai/news/kkr-to-sell-infinity-transportation-to-ares-for-2-9-billion-5e31b259Stockwhizen2026-10-19T10:50:00.082ZKKR to Sell Infinity Transportation to Ares for $2.9 Billionhttps://stockwhiz.ai/news/biontech-to-showcase-oncology-late-stage-pipeline-progress-and-pumitam-4df1c36dStockwhizen2026-10-19T10:45:00.412ZBioNTech to Showcase Oncology Late-Stage Pipeline Progress and Pumitamig Novel-Novel Combination Data at ESMO 2026https://stockwhiz.ai/news/brightstar-lottery-plc-to-host-third-quarter-2026-results-conference-c-6c8fe0c9Stockwhizen2026-10-19T10:45:00.213ZBrightstar Lottery PLC to Host Third Quarter 2026 Results Conference Call on Tuesday, November 10, 2026https://stockwhiz.ai/news/biontech-to-showcase-oncology-late-stage-pipeline-progress-and-pumitam-176d41b8Stockwhizen2026-10-19T10:45:00.067ZBioNTech to Showcase Oncology Late-Stage Pipeline Progress and Pumitamig Novel-Novel Combination Data at ESMO 2026https://stockwhiz.ai/news/scorpio-tankers-inc-announces-that-on-october-28-2026-the-company-plan-2e6db748Stockwhizen2026-10-19T10:44:00.101ZScorpio Tankers Inc. Announces that on October 28, 2026, the Company Plans to Issue Its Third Quarter 2026 Results and Have a Conference Callhttps://stockwhiz.ai/news/infosys-and-truist-strengthen-strategic-collaboration-to-build-a-globa-79326398Stockwhizen2026-10-19T10:32:37.594ZInfosys and Truist Strengthen Strategic Collaboration to Build a Global Capability Center in Indiahttps://stockwhiz.ai/news/under-13-a-day-vinfast-unveils-october-lease-financing-offers-for-2027-db3883e2Stockwhizen2026-10-19T10:30:02.211ZUnder $13 a Day: VinFast Unveils October Lease & Financing Offers for 2027 VF 8 and VF 9 Electric SUVshttps://stockwhiz.ai/news/immunic-appoints-jaa-roberson-as-chief-people-officer-5c278d99Stockwhizen2026-10-19T10:30:01.815ZImmunic Appoints Jaa Roberson as Chief People Officerhttps://stockwhiz.ai/news/sunshine-silver-mining-refining-advances-operational-readiness-at-the--22c93703Stockwhizen2026-10-19T10:30:01.212ZSunshine Silver Mining & Refining Advances Operational Readiness at the Sunshine Minehttps://stockwhiz.ai/news/cbiz-reports-third-quarter-and-nine-months-ended-september-30-2026-fin-82f2c0c5Stockwhizen2026-10-19T10:30:00.686ZCBIZ Reports Third-Quarter and Nine Months Ended September 30, 2026 Financial Resultshttps://stockwhiz.ai/news/fifth-third-bancorp-reports-third-quarter-2026-earnings-dbe5441dStockwhizen2026-10-19T10:30:00.532ZFifth Third Bancorp Reports Third Quarter 2026 Earningshttps://stockwhiz.ai/news/atomera-to-announce-third-quarter-2026-financial-results-and-host-webi-90930996Stockwhizen2026-10-19T10:30:00.210ZAtomera to Announce Third Quarter 2026 Financial Results and Host Webinar on Thursday, October 29, 2026https://stockwhiz.ai/news/caris-life-sciences-launches-new-national-commercial-featuring-jordan--9d654379Stockwhizen2026-10-19T10:30:00.016ZCaris Life Sciences Launches New National Commercial Featuring Jordan Spieth Highlighting the Power of Artificial Intelligence in Early Stage Cancer Detectionhttps://stockwhiz.ai/news/transocean-ltd-announces-contract-awards-totaling-550-million-bfb0fdb2Stockwhizen2026-10-19T10:10:45.094ZTransocean Ltd. Announces Contract Awards Totaling $550 Millionhttps://stockwhiz.ai/news/prth-investigation-reminder-priority-technology-shareholders-are-notif-ddaa29b1Stockwhizen2026-10-19T10:07:00.572ZPRTH Investigation Reminder: Priority Technology Shareholders are Notified to Contact BFA Law about the $8.05 per Share Take-Private Mergerhttps://stockwhiz.ai/news/pag-investigation-alert-penske-automotive-group-inc-shareholders-are-n-85c4e2ecStockwhizen2026-10-19T10:07:00.526ZPAG Investigation Alert: Penske Automotive Group, Inc. Shareholders are Notified to Contact BFA Law about the $212.00 per Share Take-Private Mergerhttps://stockwhiz.ai/news/bac-investigation-alert-bank-of-america-investors-that-lost-money-afte-dc783526Stockwhizen2026-10-19T10:07:00.338ZBAC Investigation Alert: Bank of America Investors that Lost Money after the 4% Stock Drop are Notified to Contact BFA Lawhttps://stockwhiz.ai/news/bmbl-investigation-reminder-bumble-shareholders-are-notified-to-contac-65b6c994Stockwhizen2026-10-19T10:07:00.286ZBMBL Investigation Reminder: Bumble Shareholders are Notified to Contact BFA Law about Ithaca Holdco’s $6.05 per Share Mergerhttps://stockwhiz.ai/news/veon-accelerates-telecom-market-consolidation-in-uzbekistan-a-market-o-217623daStockwhizen2026-10-19T10:05:38.285ZVEON Accelerates Telecom Market Consolidation in Uzbekistan, a Market of Nearly 40 Million Peoplehttps://stockwhiz.ai/news/veon-accelerates-telecom-market-consolidation-in-uzbekistan-a-market-o-6ae74c41Stockwhizen2026-10-19T10:05:38.045ZVEON Accelerates Telecom Market Consolidation in Uzbekistan, a Market of Nearly 40 Million Peoplehttps://stockwhiz.ai/news/ideaya-biosciences-and-servier-announce-data-from-three-clinical-trial-c3b8bda0Stockwhizen2026-10-19T10:00:02.415ZIDEAYA Biosciences and Servier Announce Data From Three Clinical Trials at ESMO 2026 Supporting the Potential of Darovasertib to Become a Foundational New Therapy for Patients Across the Treatment Journey of Uveal Melanomahttps://stockwhiz.ai/news/in-less-than-one-year-starlink-mobile-connects-11-million-people-acros-8f51449eStockwhizen2026-10-19T10:00:00.650ZIn less than one year, Starlink Mobile Connects 11 Million People Across VEON’s Three High Growth Marketshttps://stockwhiz.ai/news/cleveland-cliffs-reports-third-quarter-2026-results-6cb2a8beStockwhizen2026-10-19T10:00:00.469ZCleveland-Cliffs Reports Third-Quarter 2026 Resultshttps://stockwhiz.ai/news/perfect-announces-shareholders-approval-of-merger-agreement-6ec62fb0Stockwhizen2026-10-19T10:00:00.444ZPerfect Announces Shareholders’ Approval of Merger Agreementhttps://stockwhiz.ai/news/realtor-com-market-clock-report-buyers-gain-ground-as-mortgage-rates-t-9a8b2c4aStockwhizen2026-10-19T10:00:00.427ZRealtor.com® Market Clock® Report: Buyers Gain Ground as Mortgage Rates Top 7%https://stockwhiz.ai/news/medallion-financial-corp-announces-repurchase-of-trust-preferred-secur-acdc2cadStockwhizen2026-10-19T10:00:00.406ZMedallion Financial Corp. Announces Repurchase of Trust Preferred Securities and Successful Resolution With ZimCalhttps://stockwhiz.ai/news/one-year-in-jpmorganchase-x27-s-security-and-resiliency-initiative-is--8498248fStockwhizen2026-10-19T10:00:00.358ZOne Year In, JPMorganChase's Security and Resiliency Initiative Is Helping to Strengthen Industries Critical to Long-Term Economic Growthhttps://stockwhiz.ai/news/zymeworks-appoints-suzanne-monahan-as-senior-vice-president-commercial-6a085a97Stockwhizen2026-10-19T10:00:00.328ZZymeworks Appoints Suzanne Monahan as Senior Vice President, Commercial and General Manager, Theravance Biopharmahttps://stockwhiz.ai/news/beone-medicines-highlights-rapidly-accelerating-solid-tumor-franchise--fd337abcStockwhizen2026-10-19T10:00:00.318ZBeOne Medicines Highlights Rapidly Accelerating Solid Tumor Franchise at ESMO 2026https://stockwhiz.ai/news/advanced-energy-announces-third-quarter-2026-earnings-date-on-november-81d634c5Stockwhizen2026-10-19T10:00:00.273ZAdvanced Energy Announces Third Quarter 2026 Earnings Date on November 2https://stockwhiz.ai/news/biodesix-adds-digital-diagnostics-to-lung-pipeline-creating-new-growth-a9199a60Stockwhizen2026-10-19T10:00:00.251ZBiodesix Adds Digital Diagnostics to Lung Pipeline, Creating New Growth Platform Combining Blood and Imaging Biomarkershttps://stockwhiz.ai/news/ingram-micro-to-report-third-quarter-2026-financial-results-on-october-bf6e2f46Stockwhizen2026-10-19T10:00:00.231ZIngram Micro to Report Third Quarter 2026 Financial Results on October 29, 2026https://stockwhiz.ai/news/ethan-allen-announces-release-date-for-its-fiscal-2027-first-quarter-r-6b5f3b2cStockwhizen2026-10-19T10:00:00.170ZEthan Allen Announces Release Date for its Fiscal 2027 First Quarter Resultshttps://stockwhiz.ai/news/dole-plc-schedules-third-quarter-2026-financial-results-release-c8ff4099Stockwhizen2026-10-19T10:00:00.154ZDole plc Schedules Third Quarter 2026 Financial Results Releasehttps://stockwhiz.ai/news/belite-bio-announces-uplisting-to-the-nasdaq-global-select-market-3514c61cStockwhizen2026-10-19T10:00:00.126ZBelite Bio Announces Uplisting to the Nasdaq Global Select Markethttps://stockwhiz.ai/news/krispy-kreme-spins-up-spooky-chocolate-chaos-with-new-taz-chocolate-or-e3c69a11Stockwhizen2026-10-19T10:00:00.111ZKRISPY KREME® Spins Up Spooky Chocolate Chaos with New Taz™ Chocolate Original Glazed® Dozenhttps://stockwhiz.ai/news/in-less-than-one-year-starlink-mobile-connects-11-million-people-acros-dc991188Stockwhizen2026-10-19T10:00:00.050ZIn less than one year, Starlink Mobile Connects 11 Million People Across VEON’s Three High Growth Marketshttps://stockwhiz.ai/news/cme-group-to-launch-tungsten-futures-to-meet-rising-demand-for-critica-dfb19025Stockwhizen2026-10-19T10:00:00.013ZCME Group to Launch Tungsten Futures to Meet Rising Demand for Critical Mineralshttps://stockwhiz.ai/news/nutex-health-schedules-2026-third-quarter-financial-results-release-an-71704524Stockwhizen2026-10-19T09:30:00.019ZNutex Health Schedules 2026 Third Quarter Financial Results Release and Conference Callhttps://stockwhiz.ai/news/lilly-x27-s-omvoh-mirikizumab-mrkz-meets-primary-endpoint-of-clinical--7be454b9Stockwhizen2026-10-19T08:40:00.018ZLilly's Omvoh (mirikizumab-mrkz) meets primary endpoint of clinical remission and is the first IL-23p19 inhibitor to report one-year Phase 3 results in pediatric ulcerative colitishttps://stockwhiz.ai/news/scandic-and-hilton-sign-new-nordics-strategic-agreement-594039eaStockwhizen2026-10-19T08:00:09.435ZScandic and Hilton sign new Nordics strategic agreementhttps://stockwhiz.ai/news/abbvie-presents-data-for-abbv-466-a-novel-dual-targeting-therapy-demon-6aa14b8eStockwhizen2026-10-19T08:00:01.451ZAbbVie Presents Data for ABBV-466, a Novel Dual-Targeting Therapy Demonstrating Higher Endoscopic Remission Rates Than Either Anti-IL-23 or Anti-α4β7 Monotherapy in Moderate to Severe Crohn's Diseasehttps://stockwhiz.ai/news/niu-technologies-to-report-third-quarter-2026-financial-results-on-nov-841f2c0aStockwhizen2026-10-19T08:00:00.107ZNiu Technologies to Report Third Quarter 2026 Financial Results on Nov 16, 2026https://stockwhiz.ai/news/reminder-invitation-to-dnb-x27-s-third-quarter-presentation-wednesday--0c0fc47aStockwhizen2026-10-19T07:13:20.558ZReminder: Invitation to DNB's third quarter presentation, Wednesday, 21 October 2026https://stockwhiz.ai/news/imu-and-uk-biobank-to-generate-the-world-s-most-detailed-large-scale-p-5cd8635fStockwhizen2026-10-19T07:08:00.095ZIMU and UK Biobank to generate the world’s most detailed, large-scale picture of the human immune system for advancing research into health and diseasehttps://stockwhiz.ai/news/lazard-welcomes-david-krap-as-managing-director-and-co-head-of-europea-58c03898Stockwhizen2026-10-19T07:00:02.228ZLazard Welcomes David Krap as Managing Director and Co-Head of European Consumer, Retail & Leisurehttps://stockwhiz.ai/news/lazard-welcomes-david-krap-as-managing-director-and-co-head-of-europea-888904d6Stockwhizen2026-10-19T07:00:00.425ZLazard Welcomes David Krap as Managing Director and Co-Head of European Consumer, Retail & Leisurehttps://stockwhiz.ai/news/evaxion-reports-sustained-clinical-responses-for-all-patients-at-three-9b3af385Stockwhizen2026-10-19T07:00:00.293ZEvaxion reports sustained clinical responses for all patients at three-year follow-up in phase 2 trial with personalized cancer vaccine EVX-01https://stockwhiz.ai/news/evaxion-reports-sustained-clinical-responses-for-all-patients-at-three-204fb134Stockwhizen2026-10-19T07:00:00.073ZEvaxion reports sustained clinical responses for all patients at three-year follow-up in phase 2 trial with personalized cancer vaccine EVX-01https://stockwhiz.ai/news/christmas-flights-2026-kayak-reveals-fares-down-up-to-39-from-the-uk-d3e71e11Stockwhizen2026-10-19T07:00:00.061ZChristmas flights 2026: KAYAK reveals fares down up to 39% from the UKhttps://stockwhiz.ai/news/elbit-systems-awarded-235-million-contract-to-supply-extra-mr-rockets--24a381a6Stockwhizen2026-10-19T06:54:11.822ZElbit Systems Awarded $235 Million Contract to Supply EXTRA-MR Rockets and PULS Launchers to a European Countryhttps://stockwhiz.ai/news/reg-sunbelt-rentals-holdings-inc-share-repurchase-program-weekly-repor-b4bea03dStockwhizen2026-10-19T06:00:16.342ZREG-Sunbelt Rentals Holdings Inc.: Share Repurchase Program - Weekly Reporthttps://stockwhiz.ai/news/oculis-completes-randomization-in-predict-1-registrational-trial-of-li-40efde79Stockwhizen2026-10-19T06:00:00.436ZOculis Completes Randomization in PREDICT-1 Registrational Trial of Licaminlimab for TNFR1-Mediated Dry Eye Diseasehttps://stockwhiz.ai/news/oculis-completes-randomization-in-predict-1-registrational-trial-of-li-b1f2fbaaStockwhizen2026-10-19T06:00:00.113ZOculis Completes Randomization in PREDICT-1 Registrational Trial of Licaminlimab for TNFR1-Mediated Dry Eye Diseasehttps://stockwhiz.ai/news/reg-oculis-l-kur-slembir-un-predict-1-skr-ningarranns-kninni-licaminli-929327b4Stockwhizen2026-10-19T06:00:00.101ZREG-Oculis lýkur slembiröðun í PREDICT-1 skráningarrannsókninni á Licaminlimab við TNFR1-miðluðum augnþurrkihttps://stockwhiz.ai/news/poxel-reports-revenue-for-the-third-quarter-of-2026-b006fc97Stockwhizen2026-10-19T05:45:00.171ZPoxel Reports Revenue for the Third Quarter of 2026https://stockwhiz.ai/news/zealand-pharma-announces-positive-topline-results-from-the-multiple-as-daa7811aStockwhizen2026-10-19T05:00:00.303ZZealand Pharma announces positive topline results from the multiple ascending dose part of Phase 1 trial with Kv1.3 ion channel blocker ZP9830https://stockwhiz.ai/news/zealand-pharma-announces-positive-topline-results-from-the-multiple-as-ac6aac0aStockwhizen2026-10-19T05:00:00.183ZZealand Pharma announces positive topline results from the multiple ascending dose part of Phase 1 trial with Kv1.3 ion channel blocker ZP9830https://stockwhiz.ai/news/red-cat-announces-proposed-voluntary-public-purchase-offer-for-steyr-m-2d2779edStockwhizen2026-10-19T05:00:00.105ZRed Cat Announces Proposed Voluntary Public Purchase Offer for Steyr Motorshttps://stockwhiz.ai/news/truecaller-announces-preliminary-numbers-for-the-third-quarter-2026-9d4c6a9aStockwhizen2026-10-19T04:36:31.793ZTruecaller announces preliminary numbers for the third quarter 2026https://stockwhiz.ai/news/truecaller-announces-preliminary-numbers-for-the-third-quarter-2026-8ed53b55Stockwhizen2026-10-19T04:15:12.619ZTruecaller announces preliminary numbers for the third quarter 2026https://stockwhiz.ai/news/infleqtion-convenes-business-leaders-in-london-to-chart-quantum-commer-1445b68bStockwhizen2026-10-19T04:00:00.172ZInfleqtion Convenes Business Leaders in London to Chart Quantum Commercial Valuehttps://stockwhiz.ai/news/c-o-r-r-e-c-t-i-o-n-abbvie-6d423de7Stockwhizen2026-10-19T01:18:53.225Z/C O R R E C T I O N - AbbVie/https://stockwhiz.ai/news/ff-eai-robotics-ecosystem-inc-ffr-highlights-faraday-future-founder-an-371ca921Stockwhizen2026-10-19T00:11:05.365ZFF EAI Robotics Ecosystem Inc. (FFR) Highlights Faraday Future Founder and Global CEO YT Jia's Weekly Investor Update: Three New Product Offerings Launched; More Details on FFR's Acquisition of FFAI's Robotics Business and Independent Public Listinghttps://stockwhiz.ai/news/newmark-releases-q3-2026-seoul-office-market-report-f45b735eStockwhizen2026-10-19T00:00:00.643ZNewmark Releases Q3 2026 Seoul Office Market Reporthttps://stockwhiz.ai/news/openworld-nasdaq-opnw-signs-definitive-merger-agreement-to-acquire-blo-d020766aStockwhizen2026-10-19T00:00:00.633ZOpenWorld (NASDAQ:OPNW) Signs Definitive Merger Agreement to Acquire Blocksighthttps://stockwhiz.ai/news/openworld-nasdaq-opnw-signs-definitive-merger-agreement-to-acquire-blo-b4ec9325Stockwhizen2026-10-19T00:00:00.137ZOpenWorld (NASDAQ: OPNW) Signs Definitive Merger Agreement to Acquire Blocksighthttps://stockwhiz.ai/news/openworld-nasdaq-opnw-signs-definitive-merger-agreement-to-acquire-blo-f4d949adStockwhizen2026-10-19T00:00:00.069ZOpenWorld (NASDAQ: OPNW) Signs Definitive Merger Agreement to Acquire Blocksight as the Agentic Foundation for Its Up to $1 Billion Tokenized Solar and AI Computing Program with Meridian and Up to $130 Million IP-Backed Transaction with BeyondAIhttps://stockwhiz.ai/news/faraday-future-founder-and-global-ceo-yt-jia-shares-weekly-investor-up-f414e743Stockwhizen2026-10-18T23:30:00.076ZFaraday Future Founder and Global CEO YT Jia Shares Weekly Investor Update: FFR to Hold Listing Ceremony and First Investor Day at the Nasdaq Tower on Oct. 26; Three New Robotics Product Offerings Launchedhttps://stockwhiz.ai/news/aura-q3-2026-earnings-call-and-quarterly-results-cd8bc0fbStockwhizen2026-10-18T23:03:52.664ZAura Q3 2026 Earnings Call and Quarterly Resultshttps://stockwhiz.ai/news/esmo-2026-presentations-deepen-the-evidence-base-for-natera-s-oncology-f9ed8503Stockwhizen2026-10-18T22:10:00.075ZESMO 2026 Presentations Deepen the Evidence Base for Natera’s Oncology Portfolio and Leadership in Ultrasensitive MRD Technologyhttps://stockwhiz.ai/news/abbvie-to-present-data-at-the-2026-european-society-for-medical-oncolo-0c67610eStockwhizen2026-10-18T22:10:00.018ZAbbVie to Present Data at the 2026 European Society for Medical Oncology (ESMO) Congress Highlighting Progress Across its Expanding Solid Tumor Portfoliohttps://stockwhiz.ai/news/zentalis-pharmaceuticals-announces-first-overall-survival-data-for-aze-70bb4e4cStockwhizen2026-10-18T22:05:00.122ZZentalis Pharmaceuticals Announces First Overall Survival Data for Azenosertib from DENALI Part 1b Published in ESMO Congress 2026 Abstracthttps://stockwhiz.ai/news/eikon-therapeutics-announces-availability-of-seven-abstracts-for-prese-1bc039f9Stockwhizen2026-10-18T22:05:00.101ZEikon Therapeutics Announces Availability of Seven Abstracts for Presentation at the European Society for Medical Oncology Congresshttps://stockwhiz.ai/news/incyte-to-highlight-key-oncology-data-presentations-at-the-european-so-3bedbd53Stockwhizen2026-10-18T22:05:00.068ZIncyte to Highlight Key Oncology Data Presentations at the European Society for Medical Oncology (ESMO) Congress 2026https://stockwhiz.ai/news/lilly-to-showcase-advances-across-its-oncology-pipeline-at-the-2026-eu-bbf8c17aStockwhizen2026-10-18T22:05:00.022ZLilly to showcase advances across its oncology pipeline at the 2026 European Society for Medical Oncology (ESMO) Congresshttps://stockwhiz.ai/news/veradermics-to-hold-conference-call-to-discuss-topline-results-from-ph-d274ff0cStockwhizen2026-10-18T22:00:00.081ZVeradermics to Hold Conference Call to Discuss Topline Results from Phase 3 ‘304’ Clinical Trial of VDPHL01 in Males with Mild-to-Moderate Pattern Hair Losshttps://stockwhiz.ai/news/evercore-appoints-nigel-dawn-and-naveen-nataraj-as-co-presidents-a8116efbStockwhizen2026-10-18T21:00:00.140ZEvercore Appoints Nigel Dawn and Naveen Nataraj as Co-Presidentshttps://stockwhiz.ai/news/disc-medicine-to-host-corporate-webcast-to-discuss-topline-results-fro-84469e95Stockwhizen2026-10-18T21:00:00.092ZDisc Medicine to Host Corporate Webcast to Discuss Topline Results from the APOLLO Phase 3 Trial of Bitopertin in Erythropoietic Protoporphyria (EPP)https://stockwhiz.ai/news/where-are-the-numbers-doug-bergeron-calls-on-ethan-allen-to-release-fi-4c55f5e5Stockwhizen2026-10-18T20:00:00.072Z“Where Are the Numbers?” Doug Bergeron Calls on Ethan Allen to Release First Quarter Results Before November 4 Board Votehttps://stockwhiz.ai/news/spyre-therapeutics-announces-clinical-and-preclinical-data-presentatio-cd5a4d17Stockwhizen2026-10-18T13:30:00.094ZSpyre Therapeutics Announces Clinical and Preclinical Data Presentations at United European Gastroenterology Week (UEGW) 2026